Phage Directory Phage Directory
Community↗

Jobs

↗

14 jobs

  • Master 2 internship in marine viral ecology and bioinformatics — BEEP, Plouzané (France)
  • PhD position in bacteria and materials interactions: living hydrogels with phages and probiotics for wound infections — Biointerfaces Laboratory, Empa (St. Gallen)

Events

↗

24 upcoming

  • PRAN Virtual Undergraduate Phage Research Symposium 2026: call for abstractsOct 23, 2026

Phage alerts

↗

71 alerts

Podovirus
Ep 18: Discussion of Phage Therapy for CF Patients - Rebekah Dedrick

Capsid & Tail

↗
  • Q&A: Favorite phage production equipment

    Issue 323Jessica Sacher

News

↗

231 news items

  • Tulane Ventures invests $250,000 in Biophoundry to advance engineered phage therapies

Updates

↗

12 updates

  • Phage prohead proteases activate CBASS antiphage immunity (Science)

Where to get Phage Therapy

↗

Treatment centers, clinical trials and next steps

Learn how phage therapy works, find programs around the world, and explore questions to discuss with your care team.

Communities Societies, networks and training groups Opportunities Funding, grants and fellowships Authors 142 contributors
Send a tip or feedback Write for Capsid & Tail

Search

Find articles, people and resources across Phage Directory.

Search Phage Directory…

7,515 results

  1. UpdatesMay 1, 2026

    Bridging continuous and discrete evolution through a controllable, hypermutagenic phage-bacteria system

    Lytic selection and evolution (LySE) is a T7-based method for near-continuous directed evolution of bacterial gene clusters that keeps discrete checkpoints: a hypermutagenic T7 DNA polymerase mutates a target gene cluster carried on a T7 ph

    UpdatesPapersPhage Engineering
  2. NewsMay 1, 2026

    Cytophage announces resignation of director Will Ollerhead

    Cytophage announced that Will Ollerhead resigned as a director effective April 29, 2026. Cytophage Technologies Ltd.

    NewsIndustry
  3. NewsApr 29, 2026

    Phage therapy in France: clinical experience from PHAGEinLYON

    Tristan Ferry discusses PHAGEinLYON’s clinical experience with compassionate use and clinical trials in a talk hosted on Canal-U. Phages.fr on Canal-U

    NewsTalksMediaClinical TrialsPhage Therapy
  4. UpdatesApr 28, 2026

    V- and VL-scores unveil viral signatures and origins of protein families

    V-score and VL-score are annotation-free metrics that quantify the "virus-likeness" of protein families and genomes, released with an open-access searchable database, V-Score-Search. Applied to public protein databases they link 19-59% of p

    UpdatesPapersBioinformaticsVirology
  5. UpdatesApr 28, 2026

    Quantifying phage-host dynamics using droplet microfluidics

    A high-throughput droplet microfluidics platform co-encapsulates individual phages and bacteria to quantify single phage infection events, with control over exposure time and the phage-to-bacteria ratio. It measures lysis events and lysis k

    UpdatesPapersPhage Biology
  6. UpdatesApr 28, 2026

    Capsular specificity in temperate phages of Klebsiella pneumoniae is driven by diverse receptor-binding enzymes

    The study links temperate-phage capsule specificity with diverse receptor-binding proteins, including classical depolymerases and SGNH-domain hydrolases predicted to deacetylate polysaccharides. The team also shared English and Polish comic

    UpdatesPapersHost SpecificityProphages
  7. EventsApr 27, 2026

    4th Japanese Phage Young Researchers’ Meeting

    The fourth Japanese Phage Young Researchers’ Meeting was announced as a two-night residential gathering at the University Seminar House in Hachioji, July 29–31, 2026, for students and researchers within five years of completing a doctoral d

    EventsPhage TherapyWorkshop
  8. UpdatesApr 27, 2026

    Nuclease–NTPase antiphage defence systems use conserved molecular features to control bacterial immunity

    Large-scale comparative cell biology and biochemistry of 16 bacterial nuclease-NTPase antiphage defence systems shows that protein-protein complex formation is a shared feature. The nucleases of the Pa AbpAB, Bt Hachiman and Ec PD-T4-8 syst

    UpdatesPapersPhage Biology
  9. PodovirusApr 21, 2026

    Why phage companies aren’t raising $400M rounds… yet | Paul Garofolo

    “The thing everybody thinks is a tailwind for our space — the low financial barrier to get into a clinical trial — is actually one of the largest headwinds.” Paul has spent 35 years in biopharma, and he has a sharp take on why phage therapy

  10. NewsApr 15, 2026

    TU-K reports phage research training with PHTRP

    Researchers, students and professionals from multiple institutions took part in phage research training through a collaboration between TU-K and the Phage Hunters Training and Research Program. The programme combined online theory with hand

    NewsResearchTraining
  11. NewsApr 14, 2026

    Cytophage announces departure of COO Heather Medwick

    Cytophage announced that Chief Operating Officer Heather Medwick left the company effective March 31, 2026, as part of its corporate restructuring. Cytophage Technologies Ltd.

    NewsIndustry
  12. UpdatesApr 4, 2026

    Rage against the mean: a perspective on measuring fitness of individual phage particles

    A perspective arguing that traditional bacteriophage methods measure population averages and miss variation between individual particles. It advocates optical microscopy and flow cytometry approaches that can reveal phenotypic heterogeneity

    UpdatesPapersPhage BiologyReview
  13. PodovirusApr 3, 2026

    Chip Schooley & Graham Hatfull: the state of phage therapy (& what HIV can teach us)

    Chip Schooley (UC San Diego, IPATH) and Graham Hatfull (University of Pittsburgh) join us to discuss why phage therapy needs biologists and clinicians collaborating — and what the HIV field’s playbook can teach us. Topics covered: • Why the

  14. JobsApr 2, 2026

    Postdoctoral researcher on polymer-based bacteriophage stabilization — Institute of Physical Chemistry PAS

    The Institute of Physical Chemistry PAS (Living Materials group; project leader Dr hab. Jan Paczesny) recruited one full-time postdoctoral researcher for 12 months, with possible extension, on a National Science Centre (NCN) SHENG-4 project

    JobsPhage StabilizationPolymer Science
  15. NewsApr 1, 2026

    Buffalo reports MRSA patient’s treatment with phage therapy

    The University at Buffalo reports clearance of a patient’s chronic MRSA infection following phage therapy alongside antibiotics and hip hardware replacement. Patrick Kenney’s team developed the patient-specific phage after years of recurren

    NewsPhage Therapy
  16. NewsMar 30, 2026

    Pseudomonas aeruginosa can enter a temporary "stealth mode" to evade pili-targeting phages

    McMaster University researchers report in mBio (published March 30, 2026) that Pseudomonas aeruginosa can evade phage attack by entering a temporary "stealth mode". Of 28 phage-resistant mutants studied, one regained full pili function in a

    NewsPhage Biology
  17. NewsMar 27, 2026

    Antibiotic Apocalypse — Radiolab

    Avir Mitra explores antibiotic resistance in this Radiolab live-show episode. The episode page also links to a bacteriophage deep dive with Mitra and Steffanie Strathdee, plus a recording of the live show and bonus Q&A. Radiolab

    NewsMedia
  18. UpdatesMar 23, 2026

    Systematic review of phage therapy in people with cystic fibrosis: 51 patients in 19 studies (International Journal of Infectious Diseases)

    Terlizzi and colleagues report a systematic review in the International Journal of Infectious Diseases of phage therapy in cystic fibrosis: 19 studies covering 51 patients and 52 phage treatment courses, mostly against Pseudomonas aeruginos

    UpdatesPapersReviewPhage Therapy
  19. UpdatesMar 20, 2026

    VirHost Hunter phage-host assignment

    VirHost Hunter uses phage tails and lysins with protein language models and vision transformers to assign hosts without requiring complete phage genomes. High-resolution phage-host assignment through key proteins using large language models

    UpdatesPapers
  20. OpportunitiesMar 17, 2026

    PILAR 2026 Latin American AMR research call: closed round

    Argentina, Paraguay, Uruguay and Brazil’s São Paulo and Espírito Santo agencies jointly supported research and knowledge transfer on antimicrobial resistance in intensive food-animal production. Projects could run up to 24 months, with agen

    OpportunitiesFundingAMR
Previous Page 7 of 376 Next

Supported by

Mozilla The Leona M. and Harry B. Helmsley Charitable TrustThe Leona M. and Harry B. Helmsley Charitable Trust

Phage Directory

hello@phage.directory
@phagedirectory

Learn how we use AI in our writing, research and site development. Read more.

Capsid & Tail

Latest issue All issues Authors Podovirus RSS feed

Phage Directory

About Send a tip Community Communities Updates News Jobs Events Opportunities Where to get Phage Therapy Phage alerts